Geometric trajectory analysis of metabolic responses to toxicity can define treatment specific profiles

被引:108
作者
Keun, HC [1 ]
Ebbels, TMD [1 ]
Bollard, ME [1 ]
Beckonert, O [1 ]
Antti, H [1 ]
Holmes, E [1 ]
Lindon, JC [1 ]
Nicholson, JK [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, London SW7 2AZ, England
关键词
D O I
10.1021/tx034212w
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Metabonomics can be viewed as the process of defining multivariate metabolic trajectories that describe the systemic response of organisms to physiological perturbations through time. We have explored the hypothesis that the homothetic geometry of a metabolic trajectory, i.e., the metabolic response irrespective of baseline values and overall magnitude, defines the mode of response of the organism to treatment and is hence the key property when considering the similarity between two sets of measurements. A modeling strategy to test for homothetic geometry, called scaled-to-maximum, aligned, and reduced trajectories (SMART) analysis, is presented that together with principal components analysis (PCA) facilitates the visualization of multivariate response similarity and hence the interpretation of metabonomic data. Several examples of the utility of this approach from toxicological studies are presented as follows: interlaboratory variation in hydrazine response, CCl4 dose-response relationships, and interspecies comparison of bromobenzene toxicity. In each case, the homothetic trajectories hypothesis is shown to be an important concept for the successful multivariate modeling and interpretation of systemic metabolic change. Overall, geometric trajectory analysis based on a homothetic modeling strategy like SMART facilitates the amalgamation and comparison of metabonomic data sets and can improve the accuracy and precision of classification models based on metabolic profile data. Because interlaboratory variation, normal physiological variation, dose-response relationships, and interspecies differences are also key areas of concern in genomic and proteomic as well as metabonomic studies, the methods presented here may also have an impact on many other multilaboratory efforts to produce screenable "-omics" databases useful for gauging toxicity in safety assessment and drug discovery.
引用
收藏
页码:579 / 587
页数:9
相关论文
共 21 条
[1]  
ANTHONY ML, 1994, MOL PHARMACOL, V46, P199
[2]   Batch statistical processing of 1H NMR-derived urinary spectral data [J].
Antti, H ;
Bollard, ME ;
Ebbels, T ;
Keun, H ;
Lindon, JC ;
Nicholson, JK ;
Holmes, E .
JOURNAL OF CHEMOMETRICS, 2002, 16 (8-10) :461-468
[3]   Metabolic trajectory characterisation of xenobiotic-induced hepatotoxic lesions using statistical batch processing of NMR data [J].
Azmi, J ;
Griffin, JL ;
Antti, H ;
Shore, RF ;
Johansson, E ;
Nicholson, JK ;
Holmes, E .
ANALYST, 2002, 127 (02) :271-276
[4]   Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins [J].
Beckwith-Hall, BM ;
Nicholson, JK ;
Nicholls, AW ;
Foxall, PJD ;
Lindon, JC ;
Connor, SC ;
Abdi, M ;
Connelly, J ;
Holmes, E .
CHEMICAL RESEARCH IN TOXICOLOGY, 1998, 11 (04) :260-272
[5]   QUANTITATIVE MODELING AND BIOLOGY - THE MULTIVARIATE APPROACH [J].
BENIGNI, R ;
GIULIANI, A .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (05) :R1697-R1704
[6]   Quality review procedures necessary for rodent pathology Databases and toxicogenomic studies: The National Toxicology Program experience [J].
Boorman, GA ;
Haseman, JK ;
Waters, MD ;
Hardisty, JF ;
Sills, RC .
TOXICOLOGIC PATHOLOGY, 2002, 30 (01) :88-92
[7]  
Borowski E., 1989, Dictionary of Mathematics, V1st
[8]  
Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802
[9]   Toxicity classification from metabonomic data using a density superposition approach: 'CLOUDS' [J].
Ebbels, T ;
Keun, H ;
Beckonert, O ;
Antti, H ;
Bollard, M ;
Holmes, E ;
Lindon, J ;
Nicholson, J .
ANALYTICA CHIMICA ACTA, 2003, 490 (1-2) :109-122
[10]   An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences:: application to the C57BL10J and Alpk:ApfCD mouse [J].
Gavaghan, CL ;
Holmes, E ;
Lenz, E ;
Wilson, ID ;
Nicholson, JK .
FEBS LETTERS, 2000, 484 (03) :169-174